My Quote Request
No products added yet
6505-01-474-5599
20 Products
NDC00029-3159-20
ROSIGLITAZONE MALEA
NSN, MFG P/N
6505014745599
NSN
6505-01-474-5599
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ROSIGLITAZONE TABLET 4MG 100S
III SUPPLEMENTARY FEATURES: USED TO CONTROL TYPE 2 DIABETES MELLITUS
SPECIAL FEATURES: 4 MG; BOTTLE OF 100 TABLETS; STORE AT 25 DEGREES C (77 DEGREE F)
Related Searches:
00-0355
ROSIGLITAZONE MALEA
NSN, MFG P/N
6505014745604
NSN
6505-01-474-5604
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ROSIGLITAZONE TABLETS 8MG 100S TO CONTROL TYPE 2 DIABETES MELLITUS
III SUPPLEMENTARY FEATURES: USED TO CONTROL TYPE 2 DIABETES MELLITUS
SPECIAL FEATURES: 8 MG; BOTTLE OF 100 TABLETS; STORE AT 25 DEGREES C (77 DEGREE F)
Related Searches:
AVANDIA
ROSIGLITAZONE MALEA
NSN, MFG P/N
6505014745604
NSN
6505-01-474-5604
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ROSIGLITAZONE TABLETS 8MG 100S TO CONTROL TYPE 2 DIABETES MELLITUS
III SUPPLEMENTARY FEATURES: USED TO CONTROL TYPE 2 DIABETES MELLITUS
SPECIAL FEATURES: 8 MG; BOTTLE OF 100 TABLETS; STORE AT 25 DEGREES C (77 DEGREE F)
Related Searches:
NDC00029-3160-20
ROSIGLITAZONE MALEA
NSN, MFG P/N
6505014745604
NSN
6505-01-474-5604
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ROSIGLITAZONE TABLETS 8MG 100S TO CONTROL TYPE 2 DIABETES MELLITUS
III SUPPLEMENTARY FEATURES: USED TO CONTROL TYPE 2 DIABETES MELLITUS
SPECIAL FEATURES: 8 MG; BOTTLE OF 100 TABLETS; STORE AT 25 DEGREES C (77 DEGREE F)
Related Searches:
00-0329
BARIUM SULFATE,DIAGNOSTIC
NSN, MFG P/N
6505014747613
NSN
6505-01-474-7613
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ADMINISTRATION: ORAL, NONCHEWABLE
FLAVOR: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BARIUM SULFATE DIAGNOSTIC PILL 10GM F/SWALLOWING STUDIES 100S
PHYSICAL FORM: PILL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 UNITS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 10 GRAIN BARIUM SULFATE TABLETS FOR SWALLOWING STUDIES; 0.500 IN. DIA TABLETS FLATTENED FROM SIDE TO SIDE FACILITATING SWALLOWING, TABLETS DISINTEGRATE WITH HALF AN HOUR AND FRAGMENTS THEN PASS WITHOUT DIFFICULTY; 100 TABLETS PER BOTTLE/100 BOTTLES PER
TOTAL PRIMARY CONTAINER QUANTITY: 100
~1: CASE
Related Searches:
778
BARIUM SULFATE,DIAGNOSTIC
NSN, MFG P/N
6505014747613
NSN
6505-01-474-7613
MFG
E-Z-EM INC
Description
ADMINISTRATION: ORAL, NONCHEWABLE
FLAVOR: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BARIUM SULFATE DIAGNOSTIC PILL 10GM F/SWALLOWING STUDIES 100S
PHYSICAL FORM: PILL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 UNITS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 10 GRAIN BARIUM SULFATE TABLETS FOR SWALLOWING STUDIES; 0.500 IN. DIA TABLETS FLATTENED FROM SIDE TO SIDE FACILITATING SWALLOWING, TABLETS DISINTEGRATE WITH HALF AN HOUR AND FRAGMENTS THEN PASS WITHOUT DIFFICULTY; 100 TABLETS PER BOTTLE/100 BOTTLES PER
TOTAL PRIMARY CONTAINER QUANTITY: 100
~1: CASE
Related Searches:
00-0520
BARIUM SULFATE SUSPENSION,USP
NSN, MFG P/N
6505014748604
NSN
6505-01-474-8604
00-0520
BARIUM SULFATE SUSPENSION,USP
NSN, MFG P/N
6505014748604
NSN
6505-01-474-8604
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 13.000 PERCENTAGE, W/V BARIUM SULFATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: UNIT DOSE
FLAVOR: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BARIUM SULFATE SUSPENSION 600ML 1.38 LBS PER PLASTIC BAG 12S
PHARMACEUTICAL VEHICLE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 600.000 MILLILITERS
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 12 BAG, PLASTIC
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SECONDARY CONTAINER TYPE: CASE
TOTAL PRIMARY CONTAINER QUANTITY: 1
TOTAL SECONDARY CONTAINER QUANTITY: 1
Related Searches:
L140
BARIUM SULFATE SUSPENSION,USP
NSN, MFG P/N
6505014748604
NSN
6505-01-474-8604
MFG
E-Z-EM INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 13.000 PERCENTAGE, W/V BARIUM SULFATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: UNIT DOSE
FLAVOR: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BARIUM SULFATE SUSPENSION 600ML 1.38 LBS PER PLASTIC BAG 12S
PHARMACEUTICAL VEHICLE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 600.000 MILLILITERS
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 12 BAG, PLASTIC
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SECONDARY CONTAINER TYPE: CASE
TOTAL PRIMARY CONTAINER QUANTITY: 1
TOTAL SECONDARY CONTAINER QUANTITY: 1
Related Searches:
LIQUID ENTEROVU
BARIUM SULFATE SUSPENSION,USP
NSN, MFG P/N
6505014748604
NSN
6505-01-474-8604
LIQUID ENTEROVU
BARIUM SULFATE SUSPENSION,USP
NSN, MFG P/N
6505014748604
NSN
6505-01-474-8604
MFG
E-Z-EM INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 13.000 PERCENTAGE, W/V BARIUM SULFATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: UNIT DOSE
FLAVOR: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BARIUM SULFATE SUSPENSION 600ML 1.38 LBS PER PLASTIC BAG 12S
PHARMACEUTICAL VEHICLE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 600.000 MILLILITERS
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 12 BAG, PLASTIC
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SECONDARY CONTAINER TYPE: CASE
TOTAL PRIMARY CONTAINER QUANTITY: 1
TOTAL SECONDARY CONTAINER QUANTITY: 1
Related Searches:
NDC 32909-140-06
BARIUM SULFATE SUSPENSION,USP
NSN, MFG P/N
6505014748604
NSN
6505-01-474-8604
NDC 32909-140-06
BARIUM SULFATE SUSPENSION,USP
NSN, MFG P/N
6505014748604
NSN
6505-01-474-8604
MFG
E-Z-EM INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 13.000 PERCENTAGE, W/V BARIUM SULFATE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: UNIT DOSE
FLAVOR: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BARIUM SULFATE SUSPENSION 600ML 1.38 LBS PER PLASTIC BAG 12S
PHARMACEUTICAL VEHICLE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 600.000 MILLILITERS
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 12 BAG, PLASTIC
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SECONDARY CONTAINER TYPE: CASE
TOTAL PRIMARY CONTAINER QUANTITY: 1
TOTAL SECONDARY CONTAINER QUANTITY: 1
Related Searches:
02-2393
BRETYLIUM TOSYLATE INJECTION,USP
NSN, MFG P/N
6505014752156
NSN
6505-01-475-2156
02-2393
BRETYLIUM TOSYLATE INJECTION,USP
NSN, MFG P/N
6505014752156
NSN
6505-01-475-2156
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.0000 MILLIGRAMS BRETYLIUM TOSYLATE PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR AND INTRAVENOUS
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 240400
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BRETYLIUM TOSYLATE INJECTION 50MG/ML 10ML PLASTIC SYRINGE NO NEEDLE 10S
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: PLASTIC SYRINGE (NO NEEDLE); COMES W/PLUNGER AND SYRINGE BARREL PRE-ASSEMBLED; SYRINGE COMES W/LUER LOCK TIP; FOR USE IN THE MANAGEMENT OF VENTRICULAR ARRHYTHMIAS; STORE AT CONTROLLED ROOM TEMPERATURE 15 TO 30 DEGREES C (59 TO 86 DEGREES F)
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
ANSYR
BRETYLIUM TOSYLATE INJECTION,USP
NSN, MFG P/N
6505014752156
NSN
6505-01-475-2156
ANSYR
BRETYLIUM TOSYLATE INJECTION,USP
NSN, MFG P/N
6505014752156
NSN
6505-01-475-2156
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.0000 MILLIGRAMS BRETYLIUM TOSYLATE PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR AND INTRAVENOUS
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 240400
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BRETYLIUM TOSYLATE INJECTION 50MG/ML 10ML PLASTIC SYRINGE NO NEEDLE 10S
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: PLASTIC SYRINGE (NO NEEDLE); COMES W/PLUNGER AND SYRINGE BARREL PRE-ASSEMBLED; SYRINGE COMES W/LUER LOCK TIP; FOR USE IN THE MANAGEMENT OF VENTRICULAR ARRHYTHMIAS; STORE AT CONTROLLED ROOM TEMPERATURE 15 TO 30 DEGREES C (59 TO 86 DEGREES F)
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
ANSYR SYRINGE
BRETYLIUM TOSYLATE INJECTION,USP
NSN, MFG P/N
6505014752156
NSN
6505-01-475-2156
ANSYR SYRINGE
BRETYLIUM TOSYLATE INJECTION,USP
NSN, MFG P/N
6505014752156
NSN
6505-01-475-2156
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.0000 MILLIGRAMS BRETYLIUM TOSYLATE PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR AND INTRAVENOUS
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 240400
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BRETYLIUM TOSYLATE INJECTION 50MG/ML 10ML PLASTIC SYRINGE NO NEEDLE 10S
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: PLASTIC SYRINGE (NO NEEDLE); COMES W/PLUNGER AND SYRINGE BARREL PRE-ASSEMBLED; SYRINGE COMES W/LUER LOCK TIP; FOR USE IN THE MANAGEMENT OF VENTRICULAR ARRHYTHMIAS; STORE AT CONTROLLED ROOM TEMPERATURE 15 TO 30 DEGREES C (59 TO 86 DEGREES F)
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00074-1698-10
BRETYLIUM TOSYLATE INJECTION,USP
NSN, MFG P/N
6505014752156
NSN
6505-01-475-2156
NDC00074-1698-10
BRETYLIUM TOSYLATE INJECTION,USP
NSN, MFG P/N
6505014752156
NSN
6505-01-475-2156
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.0000 MILLIGRAMS BRETYLIUM TOSYLATE PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR AND INTRAVENOUS
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 240400
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BRETYLIUM TOSYLATE INJECTION 50MG/ML 10ML PLASTIC SYRINGE NO NEEDLE 10S
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: PLASTIC SYRINGE (NO NEEDLE); COMES W/PLUNGER AND SYRINGE BARREL PRE-ASSEMBLED; SYRINGE COMES W/LUER LOCK TIP; FOR USE IN THE MANAGEMENT OF VENTRICULAR ARRHYTHMIAS; STORE AT CONTROLLED ROOM TEMPERATURE 15 TO 30 DEGREES C (59 TO 86 DEGREES F)
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00517-8810-01
BRETYLIUM TOSYLATE INJECTION,USP
NSN, MFG P/N
6505014752156
NSN
6505-01-475-2156
NDC00517-8810-01
BRETYLIUM TOSYLATE INJECTION,USP
NSN, MFG P/N
6505014752156
NSN
6505-01-475-2156
MFG
LUITPOLD PHARMACEUTICALS INC OSTEOHEALTH COMPANY OSTEOHEALTH DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.0000 MILLIGRAMS BRETYLIUM TOSYLATE PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR AND INTRAVENOUS
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 240400
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BRETYLIUM TOSYLATE INJECTION 50MG/ML 10ML PLASTIC SYRINGE NO NEEDLE 10S
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE
SPECIAL FEATURES: PLASTIC SYRINGE (NO NEEDLE); COMES W/PLUNGER AND SYRINGE BARREL PRE-ASSEMBLED; SYRINGE COMES W/LUER LOCK TIP; FOR USE IN THE MANAGEMENT OF VENTRICULAR ARRHYTHMIAS; STORE AT CONTROLLED ROOM TEMPERATURE 15 TO 30 DEGREES C (59 TO 86 DEGREES F)
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
00-0400
HEPATITIS B VIRUS VACCINE,INACTIVATED,MODIFIED
NSN, MFG P/N
6505014753038
NSN
6505-01-475-3038
00-0400
HEPATITIS B VIRUS VACCINE,INACTIVATED,MODIFIED
NSN, MFG P/N
6505014753038
NSN
6505-01-475-3038
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HEPATITIS B VIRUS VACCINE INACTIVATED MODIFIED SGL DOSE VIAL 10S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C AND SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: RECOMMENDED VACCINATION REGIMENS CONSISTS OF 3 DOSES AT 5MCG EACH; TO BE ADMINISTERED AS FOLLOWS: FIRST DOSE AT ELECTED DATE; SECOND DOSE 1 MONTH LATER; THIRD DOSE 6 MONTHS AFTER THE FIRST DOSE
IMMEDIATE CONTAINER QUANTITY: 10
IMMEDIATE CONTAINER TYPE: VIAL, SINGLE DOSE
QUANTITY WITHIN EACH IMMEDIATE CONTAINER: 10DOSES AND 5MCG/0.5ML VIALS
SPECIAL FEATURES: VACCINE PRESERVATIVE FREE AND THIMEROSAL FREE;RECOMBIVAX HB (RECOMBINANT) IS FOR INTRAMUSCULAR INJECTION; FOR USE IN INFANTS, CHILDREN AND ADOLESCENTS (AGES 0-19); DOSAGE SUPPLIED AS 5 MCG/0.5 ML OF HBSAG (SURFACE ANTIGEN) IN A 0.5 ML SINGLE-DOSE VIAL;
UNIT PACKAGE TYPE: PACKAGE
~1: PACKAGE OR BOX OF 10; NO MORE THAN 1 PERCENT YEAST PROTEIN AND FREE OF ASSOCIATION WITH HUMAN BLOOD OR BLOOD PRODUCTS; SHAKE WELL BEFORE USE
Related Searches:
NDC00006-4981-00
HEPATITIS B VIRUS VACCINE,INACTIVATED,MODIFIED
NSN, MFG P/N
6505014753038
NSN
6505-01-475-3038
NDC00006-4981-00
HEPATITIS B VIRUS VACCINE,INACTIVATED,MODIFIED
NSN, MFG P/N
6505014753038
NSN
6505-01-475-3038
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HEPATITIS B VIRUS VACCINE INACTIVATED MODIFIED SGL DOSE VIAL 10S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C AND SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: RECOMMENDED VACCINATION REGIMENS CONSISTS OF 3 DOSES AT 5MCG EACH; TO BE ADMINISTERED AS FOLLOWS: FIRST DOSE AT ELECTED DATE; SECOND DOSE 1 MONTH LATER; THIRD DOSE 6 MONTHS AFTER THE FIRST DOSE
IMMEDIATE CONTAINER QUANTITY: 10
IMMEDIATE CONTAINER TYPE: VIAL, SINGLE DOSE
QUANTITY WITHIN EACH IMMEDIATE CONTAINER: 10DOSES AND 5MCG/0.5ML VIALS
SPECIAL FEATURES: VACCINE PRESERVATIVE FREE AND THIMEROSAL FREE;RECOMBIVAX HB (RECOMBINANT) IS FOR INTRAMUSCULAR INJECTION; FOR USE IN INFANTS, CHILDREN AND ADOLESCENTS (AGES 0-19); DOSAGE SUPPLIED AS 5 MCG/0.5 ML OF HBSAG (SURFACE ANTIGEN) IN A 0.5 ML SINGLE-DOSE VIAL;
UNIT PACKAGE TYPE: PACKAGE
~1: PACKAGE OR BOX OF 10; NO MORE THAN 1 PERCENT YEAST PROTEIN AND FREE OF ASSOCIATION WITH HUMAN BLOOD OR BLOOD PRODUCTS; SHAKE WELL BEFORE USE
Related Searches:
RECOMBIVAX HB
HEPATITIS B VIRUS VACCINE,INACTIVATED,MODIFIED
NSN, MFG P/N
6505014753038
NSN
6505-01-475-3038
RECOMBIVAX HB
HEPATITIS B VIRUS VACCINE,INACTIVATED,MODIFIED
NSN, MFG P/N
6505014753038
NSN
6505-01-475-3038
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HEPATITIS B VIRUS VACCINE INACTIVATED MODIFIED SGL DOSE VIAL 10S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C AND SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: RECOMMENDED VACCINATION REGIMENS CONSISTS OF 3 DOSES AT 5MCG EACH; TO BE ADMINISTERED AS FOLLOWS: FIRST DOSE AT ELECTED DATE; SECOND DOSE 1 MONTH LATER; THIRD DOSE 6 MONTHS AFTER THE FIRST DOSE
IMMEDIATE CONTAINER QUANTITY: 10
IMMEDIATE CONTAINER TYPE: VIAL, SINGLE DOSE
QUANTITY WITHIN EACH IMMEDIATE CONTAINER: 10DOSES AND 5MCG/0.5ML VIALS
SPECIAL FEATURES: VACCINE PRESERVATIVE FREE AND THIMEROSAL FREE;RECOMBIVAX HB (RECOMBINANT) IS FOR INTRAMUSCULAR INJECTION; FOR USE IN INFANTS, CHILDREN AND ADOLESCENTS (AGES 0-19); DOSAGE SUPPLIED AS 5 MCG/0.5 ML OF HBSAG (SURFACE ANTIGEN) IN A 0.5 ML SINGLE-DOSE VIAL;
UNIT PACKAGE TYPE: PACKAGE
~1: PACKAGE OR BOX OF 10; NO MORE THAN 1 PERCENT YEAST PROTEIN AND FREE OF ASSOCIATION WITH HUMAN BLOOD OR BLOOD PRODUCTS; SHAKE WELL BEFORE USE
Related Searches:
8547007-10LT
MICRO PAK
NSN, MFG P/N
6505014758718
NSN
6505-01-475-8718
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
SPECIAL FEATURES: DILUENT AND LYTIC REAGENT
Related Searches:
8546929-1LT
CLENZ
NSN, MFG P/N
6505014758719
NSN
6505-01-475-8719
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
SPECIAL FEATURES: CLEANING AGENT; ALL PURPOSE CLEANING REAGENT; AGENTS THAT STRIP AWAY PROTEIN BUILD UP AND LYSED RED BLOOD CELLS IN INSTRUMENT FLUIDICS; 500ML LIQUID
